THE PHYSICAL PERFORMANCE OF SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS WITH LOW DISEASE ACTIVITY: COULD THE CARDIOPULMONARY EXERCISE TESTING REFINE ITS ASSESSMENT?

被引:0
|
作者
Gusetu, G. [1 ]
Mociran, A. [2 ]
Pamfil, C. [3 ]
Damian, L. [2 ]
Pop, D. [1 ]
Zdrenghea, D. [1 ]
Rednic, S. [3 ]
机构
[1] Univ Med & Pharm, Cardiol, Cluj Napoca, Romania
[2] Cty Emergency Hosp, Rheumatol, Cluj Napoca, Romania
[3] Univ Med & Pharm, Rheumatol, Cluj Napoca, Romania
关键词
D O I
10.1136/annrheumdis-2017-eular.6619
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
SAT0285
引用
收藏
页码:880 / 881
页数:2
相关论文
共 50 条
  • [31] Low Disease Activity in Systemic Lupus Erythematosus: An Achievable Goal?
    Tani, Chiara
    Vagelli, Roberta
    Stagnaro, Chiara
    Carli, Linda
    Signorini, Viola
    Mosca, Marta
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [32] Remission or low disease activity as a target in systemic lupus erythematosus
    Francisco Ugarte-Gil, Manuel
    Wojdyla, Daniel
    Pons-Estel, Guillermo J.
    Pons-Estel, Bernardo A.
    Alarcon, Graciela S.
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 (01)
  • [33] Toward the Definition of Low Disease Activity in Systemic Lupus Erythematosus
    Polachek, Ari
    Gladman, Dafna
    JOURNAL OF RHEUMATOLOGY, 2016, 43 (06) : 1186 - 1187
  • [34] Low Disease Activity Early in the Course of Systemic Lupus Erythematosus
    Ugarte-Gil, Manuel F.
    Alarcon, Graciela S.
    JOURNAL OF RHEUMATOLOGY, 2024, 51 (08) : 739 - 740
  • [35] RELIABILITY OF PATIENTS' ASSESSMENT OF DISEASE ACTIVITY IN SYSTEMIC LUPUS ERYTHEMATOSUS: SCALES AND TIMING OF THEIR APPLICATION
    Elera-Fitzcarral, Claudia
    Vega, Karen
    Gamboa-Cardenas, Rocio V.
    Zuniga, Katiuska
    Zevallos, Francisco
    Reategui-Sokolova, Cristina
    Pastor-Asurza, Cesar
    Perich-Campos, Risto
    Bellido, Zoila Rodriguez
    Alarcon, Graciela S.
    Calvo, Armando
    Ugarte-Gil, Manuel F.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2018, 24 : S42 - S42
  • [36] Validation of disease activity self-assessment tool in systemic lupus erythematosus patients
    Sushchuk, EA
    Stepanova, NN
    Brenes-Kesada, EG
    Chashchina, AV
    Zborovskaya, IA
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 234 - 234
  • [37] Assessment of Interleukin 17 in Egyptian Systemic Lupus Erythematosus Patients as a Biomarker in Disease Activity
    Behiry, Mervat
    Wadie, Mary
    Mohamed, Nagwa Abdelghaffar
    Farid, Rania
    Ramadan, Hala
    CURRENT RHEUMATOLOGY REVIEWS, 2024, 20 (05) : 534 - 543
  • [38] Remission and low disease activity state prevent hospitalizations in systemic lupus erythematosus patients
    Reategui-Sokolova, C.
    Rodriguez-Bellido, Z.
    Gamboa-Cardenas, R. V.
    Medina, M.
    Zevallos, F.
    Pimentel-Quiroz, V. R.
    Elera-Fitzcarrald, C.
    Cucho-Venegas, M.
    Pastor-Asurza, C. A.
    Perich-Campos, R.
    Alarcon, G. S.
    Ugarte-Gil, M. F.
    LUPUS, 2019, 28 (11) : 1344 - 1349
  • [39] Complement Activation in Systemic Lupus Erythematosus Patients with Low Disease Activity Is Not Inhibited by Hydroxychloroquine
    Troldborg, Anne Margrethe
    Hansen, Annette
    Stengaard-Pedersen, Kristian
    Thiel, Steffen
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [40] Vitamin D in Colombian patients with systemic lupus erythematosus and its correlation with disease activity
    Cardona-Cardona, Andres F.
    Ceron, Jairo A.
    LUPUS, 2020, 29 (10) : 1297 - 1304